Down-regulation of rat brain 5-HT uptake carriers after treatment with high doses of D-fenfluramine

Brain Research

Volumn 730, Issue 1-2, 1996, Pages 165-172

  Gobbi, Marco ^a   Mancini, Laura ^a   Presti, Maria Laura ^a   Mennini, Tiziana ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

D fenfluramine; neurotoxicity; rat brain; serotonin release; serotonin uptake carrier; synaptosome

Indexed keywords

5,7 DIHYDROXYTRYPTAMINE; FENFLURAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; BRAIN CORTEX; BRAIN SYNAPTOSOME; CONTROLLED STUDY; HIPPOCAMPUS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; SEROTONIN RELEASE; SEROTONIN UPTAKE;

ANIMALS; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; FENFLURAMINE; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; STEREOISOMERISM; TIME FACTORS;

EID: 0030593704     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)00435-0     Document Type: Article

References (27)

1. [1] Appel, N.M., Contrera, J.F. and De Souza, E.B., Fenfluramine selectively and differentially decreases the density of serotonergic nerve terminals in rat brain: evidence from immunocytochemical Studies, J. Pharmacol. Exp. Ther., 249 (1989) 928-943.
2. [2] Appel, N.M., Mitchell, W.M., Contrera, J.F. and De Souza, E.B., Effects of high-dose fenfluramine treatment on monoarnine uptake sites in rat brain: assessment using quantitative autoradiography, Synapse. 6 (1990) 33-44.
3. [3] D'Amato, R.J., Largent, B.L., Snowman, A.M. and Snyder, S.H., Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine, J. Pharmacol. Exp. Ther., 242 (1987) 364-371.
4. [4] Garattini, S., Mennini, T., Bendotti, C., Invernizzi, R. and Samanin. R., Neurochemical mechanism of action of drugs which modify feeding via the serotoninergic system, Appetite, 7, suppl. (1986) 15-38.
5. [5] Gardier, A.M. and Wurtman, R.J., Persistent blockade of potassium-evoked serotonin release from rat frontocortical terminals after fluoxetine administration. Brain Res., 540 (1991) 325-330.
6. [6] Gibson, E.L., Kennedy, A.J. and Curzon, G., D-Fenfluramine-induced and D-norfenfluramine-induced hypophagia - Differential mechanisms and involvement of postsynaptic 5-HT receptors, Eur. J. Pharmacol, 242 (1993) 83-90.
7. [7] Gobbi, M., Frittoli, E. and Mennini, T., The modulation of [3H]noradrenaline and [3H]serotonin release from rat brain synaptosomes is not mediated by the alpha 2B-adrenoceptor subtype. Naunyn Schmiedebergs Arch. Pharmacol., 342 (1990) 382-386.
8. 3H]serotonin. Naunyn-Schmied. Arch. Pharmacol., 345 (1992) 1-6.
9. [9] Gobbi, M., Frittoli, E., Uslenghi, A. and Mennini, T., Evidence of an exocytotic-like release of [3H]5-hydroxytryptamine induced by D-fenfluramine in rat hippocampal synaptosomes, Eur. J. Pharmacol., 238 (1993) 9-17.
10. 1A receptors and 5-HT uptake sites in the rat brain, J. Chem. Neuroanatomy., 7 (1994) 65-73.
11. [11] Gray, E.G. and Whittaker, V.P., The isolation of nerve endings from brain; An electron-microcsope study of cell fragments derived by homogenization and centrifugation, J. Anat., 96 (1962) 79-87.
12. [12] Kalia, M., Reversible, short-lasting, and dose-dependent effect of ( + )-fenfluramine on neocortical serotonergic axons, Brain Res., 548 (1991) 111-125.
13. [13] Kalia, M. and O'Malley, N. P., Brain serotonergic neurons demonstrate normal axonal transport following short-and long-term treatment with dexfenfluramine. Soc. Neurosci. Abstr., 19 (1993) 1060.
14. [14] Kleven, M.S. and Seiden, L.S., D-, L-. and DL-fenfluramine cause long-lasting depletions of serotonin in rat brain, Brain Res., 505 (1989) 351-353.
15. [15] McCann, U., Hatzidimitriou, G., Ridenour, A., Fischer, C., Yuan, J., Katz, J. and Ricaurte, G., Dexfenfluramine and serotonin neurotoxicity: further preclinical evidence that clinical caution is indicated, J. Pharmacol. Exp. Ther., 269 (1994) 792-798.
16. [16] Mennini, T., Bizzi, A., Caccia, S., Codegoni, A., Fracasso, C., Frittoli, E., Guiso, G., Martin Padura, I., Taddei, C., Uslenghi, A. and Garattini, S., Comparative studies on the anorectic activity of D-fenfluramine in mice, rats, and guinea pigs, Naunyn-Schmied. Arch. Pharmacol., 343 (1991) 483-490.
17. [17] Mennini, T., Garattini, S. and Caccia, S., Anorectic effect of fenfluramine isomers and metabolites: relationship between brain levels and in vitro potencies on serotonergic mechanisms, Psychopharmacol., 85 (1985) 111-114.
18. [18] Molliver, D.C. and Molliver, M.E., Anatomic evidence for a neurotoxic effect of ( ± )-fenfluramine upon serotonergic projections in the rat, Brain Res., 511 (1990) 165-168.
19. [19] Munson, P.J. and Rodbard, D., LIGAND: a versatile computerized approach for characterization of ligand-binding systems, Anal. Biochem., 107 (1980) 220-229.
20. [20] Raiteri, M., Angelini, F. and Levi, G., A simple apparatus for studying the release of neurotransmitters from synaptosomes, Eur. J. Pharmacol., 25 (1974) 411-414.
21. [21] Rattray, M., Wotherspoon, G., Savery, D., Baldessari, S., Marden, C., Priestley, J.V. and Bendotti, C., Chronic D-fenfluramine decreases serotonin transporter messenger RNA expression in dorsal raphe nucleus, Eur. J. Pharmacol. Mol. Pharm., 268 (1994) 439-442.
22. [22] Sanders-Bush, E., Bushing, J.A. and Sulser, F., Long-term effects of p-chloroamphetamine and related drugs on central serotonergic mechanisms, J. Pharmacol. Exp. Ther., 192 (1975) 33-41.
23. [23] Sarkissian, C.F., Wurtman, R.J., Morse, A.N. and Gleason, R., Effects of tluoxetine or D-fenfluramine on serotonin release from, and levels in. rat frontal cortex, Brain Res., 529 (1990) 294-301.
24. [24] Schuster, C.R., Lewis, M. and Seiden, L.S., Fenfluramine: neurotoxicity, Psychopharmacol. Bull., 22 (1986) 148-151.
25. [25] Steranka, L.R. and Sanders-Bush, E., Long-term effects of fenfluramine on central serotonergic mechanisms, Neuropharmacology, 18 (1979) 895-903.
26. [26] Westphalen, R.I. and Dodd, P.R., The nature of D,L fenfluramine-induced 5-HT reuptake transporter loss in rats, Mol. Neurobiol., 11 (1995) 165-175.
27. [27] Zaczek, R., Battaglia, G., Culp, S., Appel, N.M., Contrera, J.F. and De Souza, E.B., Effects of repeated fenfluramine administration on indices of monoamine function in rat brain: pharmacokinetic, dose response, regional specificity and time course data, J. Pharmacol. Exp. Ther., 253 (1990) 104-112.